Angioimmunoblastic T-cell lymphoma epidemiology and demographics: Difference between revisions
No edit summary |
No edit summary |
||
| Line 2: | Line 2: | ||
{{Angioimmunoblastic T-cell lymphoma}} | {{Angioimmunoblastic T-cell lymphoma}} | ||
{{CMG}}; {{AE}} {{RT}} | {{CMG}}; {{AE}} {{RT}} | ||
==Overview== | ==Overview== | ||
AILT comprises 15-20% of peripheral [[T-cell lymphomas]] and 1-2% of all [[non-Hodgkin lymphomas]].<ref name="anon1">[http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=9166827&query_hl=8&itool=pubmed_ExternalLink] | AILT comprises 15-20% of peripheral [[T-cell lymphomas]] and 1-2% of all [[non-Hodgkin lymphomas]].<ref name="anon1">[http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=9166827&query_hl=8&itool=pubmed_ExternalLink] | ||
Revision as of 17:06, 14 August 2015
|
Angioimmunoblastic T-cell lymphoma Microchapters |
|
Differentiating Angioimmunoblastic T-cell lymphoma from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Angioimmunoblastic T-cell lymphoma epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Angioimmunoblastic T-cell lymphoma epidemiology and demographics |
|
FDA on Angioimmunoblastic T-cell lymphoma epidemiology and demographics |
|
CDC on Angioimmunoblastic T-cell lymphoma epidemiology and demographics |
|
Angioimmunoblastic T-cell lymphoma epidemiology and demographics in the news |
|
Blogs on Angioimmunoblastic T-cell lymphoma epidemiology and demographics |
|
Directions to Hospitals Treating Angioimmunoblastic T-cell lymphoma |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [2]; Associate Editor(s)-in-Chief: Raviteja Guddeti, M.B.B.S. [3]
Overview
AILT comprises 15-20% of peripheral T-cell lymphomas and 1-2% of all non-Hodgkin lymphomas.[1]
Age
The typical patient with angioimmunoblastic T-cell lymphoma (AILT) is either middle-aged or elderly.
Gender
No gender preference for this disease has been observed.
References